Deloitte

Joseph is a Managing Director in Deloitte Consulting’s National Life Sciences Practice.He is the leader of the Commercial and Market Access practice. He has over 30 years of operational and technology strategy consulting experience; 28 of them serving Biopharma and MedTech companies in the Life Sciences industry; primarily in their commercial, market access, HEOR, pricing, contracting, finance, distribution, and general council functions.Areas of expertise and thought leadership are in capabilities and operating model design, operations/technology transformation, Commercial Performance Analytics, Market Access Analytics, GTN Analytics, Value-based Contracting (VBC), and Enterprise Contracts Lifecycle Management (ECLM) Operational Excellence.

Brian is a managing director at Deloitte and has more than 18 years of experience within the Life Sciences Commercial Strategy space, having served most of the world’s largest life sciences clients in the areas of market access, pricing, commercial and launch strategy. He has dedicated his career to advancing new perspectives on the growing challenge of sustainable pricing, affordability, access, and value capture for traditional, specialty, oncology and increasingly transformative drug therapies in cell & gene therapy and rare diseases – having served over 250 unique products. Brian has a passion for leadership development, coaching and mentoring and has been recognized by PharmaVoice as a Top 100 "Most Inspiring Leader" in the Life Sciences Industry.

Articles

Value/Access/Pricing:  An essential enabler for delivering on the promise of oncology innovation  

Pharmaceutical Product Pricing and Contracts Lifecycle Management: The Importance of Linking Strategy and Operations

Candy is a Partner at Monitor Deloitte’s Strategy Practice within the Life Sciences & Health Care industry. She has over 24 years of global pharmaceutical industry and strategic consulting experience, focusing on realizing growth opportunities for clients across the US, EU and Asia. She leads the Global practice’s Therapeutic Area Transformation and Product Launch Services and manages an offshore Therapeutic Area Transformation Center in India. In addition, she leads the collaboration between our federal health and life sciences services and is part of our joint government and life sciences team to support all relevant stakeholders involved in managing the COVID-19 pandemic.